UniProtKB/Swiss-Prot Q9NZC7: Variant p.Pro282Ala

WW domain-containing oxidoreductase
Gene: WWOX
Feedback?

Variant information Variant position:

282 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Alanine (A) at position 282 (P282A, p.Pro282Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (P) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs3764340 [ dbSNP | Ensembl ]

Sequence information Variant position:

282 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

414 The length of the canonical sequence.
Location on the sequence:

SHRFTDINDSLGKLDFSRLS P TKNDYWAMLAYNRSKLCNIL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SHRFTDINDSLGKLDFSRLSPTKNDYWAMLAYNRSKLCNIL

Mouse                         SHRFTDINDSSGKLDLSRLSPPRSDYWAMLAYNRSKLCNIL

Chicken                       SHRFTEIKDSSGKLDFSLLSPSKKEYWAMLAYNRSKLCNIL

Zebrafish                     SHRFTDLLDSCGNLDLDLLSPPQKNYWSLLAYNRAKLCNLL

Drosophila                    SHRFANL--PVENLAVHHLSPPPEKYWSMMAYNNAKLCNVL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 414	WW domain-containing oxidoreductase
Region	125 – 414	Interaction with MAPT
Active site	293 – 293	Proton acceptor
Modified residue	287 – 287	Phosphotyrosine; by TNK2
Alternative sequence	37 – 414	Missing. In isoform 4.
Alternative sequence	137 – 414	GFETAKSFALHGAHVILACRNMARASEAVSRILEEWHKAKVEAMTLDLALLRSVQHFAEAFKAKNVPLHVLVCNAATFALPWSLTKDGLETTFQVNHLGHFYLVQLLQDVLCRSAPARVIVVSSESHRFTDINDSLGKLDFSRLSPTKNDYWAMLAYNRSKLCNILFSNELHRRLSPRGVTSNAVHPGNMMYSNIHRSWWVYTLLFTLARPFTKSMQQGAATTVYCAAVPELEGLGGMYFNNCCRCMPSPEAQSEETARTLWALSERLIQERLGSQSG -> ATGSCHHRVLCCCPRTGGSGRDVLQQLLPLHALTRSSERRDGPDPVGAQREADPRTAWQPVRLSGAQSGWAHTPALCVSPHASARAGPLPNVPPTQIRKSKGNKSSHNRVKNLKYQWEAGNSWGKVSLFWGWARHRSLCFLVVACLKVKTCLVCRFRISLEKHQQFSFFYCYRIA. In isoform 6.
Alternative sequence	173 – 352	Missing. In isoform 5.
Alternative sequence	190 – 414	Missing. In isoform 3.
Alternative sequence	214 – 414	Missing. In isoform 7.
Mutagenesis	287 – 287	Y -> A. Loss of phosphorylation by TNK2.

Literature citations
WWOX: a candidate tumor suppressor gene involved in multiple tumor types.
Paige A.J.W.; Taylor K.J.; Taylor C.; Hillier S.G.; Farrington S.; Scott D.; Porteous D.J.; Smyth J.F.; Gabra H.; Watson J.E.V.;
Proc. Natl. Acad. Sci. U.S.A. 98:11417-11422(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; ALTERNATIVE SPLICING (ISOFORMS 1; 3 AND 7); VARIANTS LEU-98; SER-111; TRP-120; THR-179; PHE-272; ALA-282 AND HIS-314; INVOLVEMENT IN CANCERS;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.